As they proliferate, fungi expose antigens at their cell surface that are potent stimulators of the innate immune response, and yet the commensal fungus Candida albicans is able to colonize immuno competent individuals. We show that C. albicans may evade immune detection by presenting a moving immunological target. We report that the exposure of β-glucan, a key pathogen-associated molecular pattern (PAMP) located at the cell surface of C. albicans and other pathogenic Candida species, is modulated in response to changes in the carbon source. Exposure to lactate induces β-glucan masking in C. albicans via a signalling pathway that has recruited an evolutionarily conserved receptor (Gpr1) and transcriptional factor (Crz1) from other well-characterized pathways. In response to lactate, these regulators control the expression of cell-wall-related genes that contribute to β-glucan masking. This represents the first description of active PAMP masking by a Candida species, a process that reduces the visibility of the fungus to the immune system.
V
ertebrates recognize microbial pathogens via immunological synapses between host pattern recognition receptors (PRRs) and the corresponding pathogen-associated molecular patterns (PAMPs) 1 . Many PAMPs lie at the cell surface, the first point of contact with the host. The fungal cell wall is a matrix of α-and β-mannans, phosphomannans, β-glucan and chitin, each of which exerts immuno modulatory effects 1 . β-1,3-Glucan, an essential component of most fungal cell walls, is a ligand for the C-type lectin receptor dectin-1 (ref. 1) . β-Glucan recognition by dectin-1 triggers phagocytosis and killing by neutrophils and macrophages 2 . Some fungi have evolved strategies to prevent this interaction. For example, Cryptococcus neoformans expresses an anti-inflammatory polysaccharide capsule that masks β-glucan 3 . The RodA hydrophobin masks β-glucans at the Aspergillus fumigatus spore surface 4 . We show that pathogenic Candida species actively mask surface β-glucan in response to the host metabolite lactate, thereby attenuating the recognition of Candida albicans by host phagocytes.
C. albicans possesses an elastic cell wall in which β-glucan is generally buried below an outer fibrillar layer of mannan, within an inner matrix of crosslinked glucan and chitin 5 . However, β-glucan becomes exposed at bud growth sites, during yeast-hypha morphogenesis, exposure to antifungal drugs and within biofilms [6] [7] [8] [9] . Moreover, β-glucan exposure increases during systemic infection 7 , in a remodelling process partly mediated by host cell antifungal activity 10 . Indeed, the C. albicans cell wall undergoes significant remodelling in response to host-derived inputs, including changes in carbon source, oxygen levels and iron availability 11, 12 , or after in vitro exposure to antifungal drugs 7 . Specific signalling pathways mediate C. albicans cell wall remodelling in response to genetic perturbation or antifungal drug treatments 7 . These include the Mkc1 cell integrity pathway, the Hog1 stress response pathway, the Cek1 pathway and Ca 2+ -calcineurin (Cna1) signalling [13] [14] [15] . However, the signalling pathways that drive cell wall remodelling in response to nutritional signals remain obscure.
Changes in carbon source lead to alterations in cell wall structure, affect immune surveillance and enhance the virulence of C. albicans 12, 16 . The carbon sources available to support fungal growth and colonization differ between host niches. Some contain glucose (for example, blood), some lack glucose (for example, the colon), while others contain significant concentrations of carboxylic acids such as lactate (for example, the vagina and colon) 17, 18 . Here, we define the mechanisms by which the carbon source affects β-glucan exposure and immune surveillance. We show that C. albicans exploits conserved signalling elements to actively mask this major PAMP in response to the physiologically relevant carboxylic acid L-lactate. Furthermore, we show that this phenomenon is conserved in other pathogenic Candida species.
Lactate triggers β-glucan masking in Candida pathogens
The architecture of the C. albicans cell wall changes significantly with carbon source. Cells grown on lactate possess thinner, less elastic cell walls than glucose-grown cells 12, 19 . Although the proportion of β-glucan relative to mannan and chitin remains similar 12 , we reasoned that β-glucan organization and exposure at the C. albicans cell surface might be affected by carbon source. To test this, cells were stained with Fc-dectin-1 and median fluorescence intensity (MFI) was quantified by flow cytometry. Glucose-grown cells displayed a biphasic distribution of β-glucan exposure (Fig. 1a,i) . The low exposure population generally contained small cells, whereas larger cells demonstrated higher levels of β-glucan exposure, consistent with mothers with bud scars as previously described 7, 9 . In contrast, lactate-grown cells displayed a monophasic population of smaller, proliferating mother and daughter cells (Fig. 1a,i) . Glucose-grown cells reproducibly displayed higher levels of β-glucan exposure than lactate-grown cells. Significantly, cells grown on a mixture of glucose plus lactate, which were similar in size to glucose-grown cells, exhibited reduced levels of β-glucan exposure, equivalent to lactate-grown cells (Fig. 1b and Supplementary Fig. 1a) . Therefore, lactate triggers β-glucan masking even in the presence of glucose. (We defined β-glucan masking as a >50% reduction in MFI.) These changes in β-glucan exposure are carbon-source-dependent, not pH-dependent ( Supplementary Fig. 1b) . β-Glucan masking is retained over long periods ( Supplementary Fig. 1c ), but is reversible ( Supplementary  Fig. 1d ). β-Glucan exposure increased within 1 h (<1 generation) of transferring lactate-grown cells to glucose, while β-glucan masking occurred within 6 h of adding lactate to glucose-grown cells and was retained throughout 72 h growth on lactate (∼51 generations).
This lactate-induced β-glucan masking phenotype was observed in almost all C. albicans clinical isolates examined ( Supplementary  Fig. 2 ). (The molecular basis for the single exception, Clade 4 strain S20175.016, is discussed below.) These blood, oral, vaginal, nail and animal isolates were from eight epidemiological clades 20 . Other pathogenic yeasts in the CTG clade (characterized by the translation of CUG codons as serine instead of leucine), including C. albicans, C. dubliniensis, C. lusitaniae, C. parapsilosis and C. orthopsilosis, displayed lactate-induced β-glucan masking (Fig. 1a,ii-iv) . Wild-type C. albicans, C. dubliniensis, C. lusitaniae, C. parapsilosis, C. glabrata and S. cerevisiae were grown in glucose or lactate and examined for β-glucan masking. The plots and MFIs are shown for glucose-grown cells (red; MFI value in top right of each panel) and lactate-grown cells (blue; MFI value, top left). β-Glucan masking was defined as a >50% decrease in MFI. Plots are representative of data collected in two independent replicate experiments. b, β-Glucan exposure for C. albicans cells grown in glucose (red) or glucose + lactate (purple). c, Percentage of glucose-or lactate-grown C. albicans cells phagocytosed by murine BMDMs (n = 4 donor mice). Measurements were performed in triplicate per mouse per condition and analysed using the Mann-Whitney U-test. Median values plus error bars of 95% CI are shown. d, Percentage of neutrophils recruited to the site of injection in BALB/c mice intraperitoneally infected with wild-type C. albicans pre-grown on glucose or lactate (for each group, n = 6 mice). Data were analysed using the Mann-Whitney U-test. Median values plus error bars of 95% CI are shown. e,f, TNFα (e) and MIP1α (f) responses from human M1-activated monocyte-derived macrophages to glucose-and lactate-grown cells; n = 4 donors exposed to triplicate independent samples of Candida cells for each condition. Data were analysed using the Friedman test for matched non-parametric data. Median values plus error bars of 95% CI are shown. Candida glabrata is more closely related to S. cerevisiae than to the other Candida species, yet masking was observed for C. glabrata but not S. cerevisiae (Fig. 1a,v,vi) . Many pathogenic Candida species therefore display lactate-dependent masking, suggesting that this phenotype might promote immune evasion and hence a pathogenic lifestyle.
C. albicans growth on lactate reduces phagocytic recruitment
Lactate-grown C. albicans cells stimulate less IL-17 production by human peripheral blood mononuclear cells (PBMCs) and are phagocytosed less efficiently by J774.1 macrophages than glucose-grown cells 16 . We recapitulated these observations with murine bone marrow-derived macrophages (BMDMs) and also demonstrated that lactate attenuates neutrophil recruitment during infection in vivo (Fig. 1c,d ). Lactate-grown cells recruited fewer neutrophils to the intraperitoneal space than glucose-grown cells (P = 0.0022) (Fig. 1d) . No difference was observed in the total number of CD45 + immune cells collected (P = 0.94), but recruitment of (CD11b + Ly6C high ) inflammatory monocytes was increased ( Supplementary  Fig. 3a) . Furthermore, lactate-grown cells stimulated less tumournecrosis factor-α (TNFα) (P = 0.0005) and less MIP1α (P < 0.0001) from human M1-activated monocyte-derived macrophages than glucose-grown cells ( 
β-Glucan masking does not depend on lactate metabolism
Lactate exists as two isomers, D-and L-lactate. C. albicans does not metabolize D-lactate, but assimilates L-lactate, the form generated by the host. Gastrointestinal microbiota secrete D-and L-lactate. The above work used a racemic mixture of D/L-lactate (1:1), so we tested each enantiomer separately. β-Glucan masking was triggered by L-lactate, but not by its D isomer (Fig. 2a) . Furthermore, β-glucan masking was activated by spent culture medium from macrophages (L-lactate) or the gut bacterium Lactobacillus reuteri, (D-and L-lactate) (Fig. 2b) . Therefore, β-glucan masking is triggered by the lactate isomer of physiological relevance to both host niches and the gut microbiota.
We tested whether lactate metabolism is essential for β-glucan masking. In C. albicans, lactate assimilation depends on uptake via the Jen1/2 transporters 21 and the glyoxylate cycle enzyme isocitrate lyase (Icl1) 17 . Lactate-induced β-glucan masking persisted in icl1Δ single and jen1Δ jen2Δ double mutants ( Supplementary  Fig. 4 ). Therefore, β-glucan masking is not dependent on lactate metabolism.
Gpr1 is a lactate sensor in C. albicans
Lactate sensors have been described in mammals and fish. For example, lactate stimulates lipolysis in mammalian adipocytes via the G-protein coupled receptor GPR81, and key lactate binding residues have been defined 22 . We identified Gpr1 as the closest C. albicans orthologue of human GPR81. In C. albicans, Gpr1 and its Gα protein Gpa2 activate cyclic adenosine monophosphate (cAMP) signalling to promote yeast-hypha morphogenesis and virulence 23 . In S. cerevisiae, the Gpr1 ligand is glucose, and its glucose binding site has been defined experimentally 24 . The ligand binding regions from ScGpr1 and CaGpr1 diverge at key residues ( Supplementary Fig. 5 ), consistent with a change in ligand specificity. Indeed, methionine, rather than glucose, has been proposed as the CaGpr1 ligand 23 . Given the structural relatedness between L-lactate and L-methionine ( Supplementary Fig. 5 ), we tested whether Gpr1 mediates lactate-induced β-glucan masking. Masking was lost in the gpr1Δ gpa2Δ double mutant (Fig. 2c) , significantly attenuated in gpr1Δ cells, and partially attenuated in gpa2Δ cells relative to their CAI4 parent ( Fig. 2c and Supplementary Fig. 6a ,c), indicating that this phenotype is dependent on Gpr1 and partially on its G-alpha protein Gpa2. As described above, C. albicans S20175.016 did not display lactate-induced β-glucan masking ( Supplementary Fig. 2 ). Sequencing of both GPR1 alleles from this strain revealed nonsynonymous single nucleotide polymorphisms (SNPs) relative to GPR1 from SC5314. Transforming GPR1 from SC5314 into S20175.016 was sufficient to restore lactate-induced β-glucan masking (Fig. 2c) , confirming that Gpr1 is required for this phenotype. We examined the impact of lactate on the localization of Gpr1-GFP in C. albicans. Gpr1-GFP localizes to the cell surface in C. albicans grown on minimal medium containing glucose 23 . In our hands, Gpr1-GFP localized to the cell surface and vesicles under these conditions (Fig. 2d,i) , suggesting dynamic cycling of this receptor. Following lactate addition, Gpr1-GFP was internalized (Fig. 2d ,iv-vi). Methionine also triggers Gpr1-GFP internalization 23 . We recapitulated this response, but only at non-physiological concentrations (100 mM), and methionine did not activate β-glucan masking (Fig. 2d ,ii,iii,f ). Pyruvate promoted partial masking, which was lost in the gpr1Δ gpa2Δ background (Fig. 2f and Supplementary Fig. 6b ). Neither proline nor acetate triggered β-glucan masking, or promoted Gpr1-GFP internalization (Fig. 2e,f) . In contrast, lactate consistently stimulated robust Gpr1-GFP internalization and β-glucan masking at low concentrations (2 mM, 10 mM; Fig. 6b ). These data highlight the specificity of Gpr1-dependent lactate-induced masking.
β-Glucan masking does not depend on cAMP signalling C. albicans Gpr1 and Gpa2 act upstream of the cAMP pathway to activate yeast-hypha morphogenesis 23 . We therefore examined lactate-induced β-glucan masking in C. albicans cyr1Δ cells lacking adenylyl cyclase, which are defective in cAMP signalling and display cell wall defects. These cells exhibited abnormally high β-glucan exposure (Supplementary Fig. 7a ). However, lactate still induced β-glucan masking (Supplementary Fig. 7a) . Similarly, β-glucan masking persisted in pde2Δ cells lacking the inhibitory cyclic phosphodiesterase (Supplementary Fig. 7a ). Furthermore, exogenous cAMP did not influence β-glucan masking (Supplementary Fig. 7a) . We conclude that, despite the involvement of Gpr1, lactate-induced β-glucan masking is not mediated by cAMP signalling.
These data suggest that Gpr1 plays dual roles in morphogenetic regulation 23 and lactate-induced β-glucan masking (Fig. 2) . In other systems, G-protein coupled receptor specificity is mediated by a ligand-specific interaction with G-alpha subunits 25 . We therefore investigated the role of the second G-alpha subunit, Cag1. A cag1Δ strain exhibited constitutive β-glucan masking ( Supplementary Fig. 6a,c) , suggesting that Cag1 plays an inhibitory role in this process. Therefore, Cag1 and Gpa2 may modulate the specificity of Gpr1 signalling to the β-glucan masking and cAMP pathways via mechanisms that remain to be defined.
We further tested whether key morphogenetic signalling pathways mediate lactate-induced β-glucan masking. Cells lacking Efg1 and Cph1, which regulate hyphal development and are targets of cAMP and mitogen-activated protein kinase (MAPK) signalling, respectively, displayed normal lactate-induced β-glucan masking (Supplementary Fig. 7b) . Furthermore, inactivation of Cek1, an extracellular signal-regulated kinase (ERK) family protein kinase that regulates Cph1 and influences cell wall structure and β-glucan 15 , did not perturb masking (Supplementary Fig. 7c ). Nor was masking affected in cla4Δ or cst20Δ cells ( Supplementary Fig. 7d,e) , which lack Ste20p-like kinases for Cek1-Cph1 signalling 26 . Therefore, lactate-induced β-glucan masking is not dependent on morphogenetic signalling via the MAPK or cAMP pathways.
Lactate-induced β-glucan masking is Crz1-dependent
To identify regulators of lactate-induced β-glucan masking, we examined transcription factors known to influence cell wall organization. This revealed the involvement of Crz1, which regulates membrane integrity, antifungal drug tolerance and cell wall remodelling 13, 27 . Lactate-induced β-glucan masking was blocked in C. albicans crz1Δ cells, and this defect was suppressed by CRZ1 reintegration (Fig. 3a) .
In C. albicans, Crz1 is activated by the calcineurin pathway in response to calcium and cell wall stress. Under these conditions, calcineurin signalling is blocked by deletion of CNA1 (encoding the catalytic subunit of calcineurin) or CNB1 (encoding the regulatory subunit), or by pharmacological inhibition of calcineurin by FK506 (ref. 28 ). However, lactate-induced β-glucan masking was not perturbed in cna1Δ or cnb1Δ cells or in wild-type cells treated with FK506 (Fig. 3a) , suggesting that lactate-dependent Crz1 activation is not mediated via calcineurin.
Calcineurin controls Crz1 localization in response to calcium 28 . In C. albicans, Ca 2+ triggers calcineurin-mediated dephosphorylation of Crz1, leading to its nuclear accumulation 28 . We recapitulated this observation (Fig. 3b) and observed that lactate also triggers nuclear accumulation of GFP-Crz1 (Fig. 3b) . Significantly, the nuclear accumulation of GFP-Crz1 was reduced in gpr1Δ gpa2Δ cells in response to lactate, but not in response to calcium (Fig. 3b ). In contrast, loss of CNB1 prevented GFP-Crz1 nuclear accumulation in response to calcium, but not in response to lactate (Fig. 3b) . We conclude that Crz1 is activated by alternative signalling pathways depending on the nature of the input signal. Although Crz1 is activated via calcineurin in response to calcium 28 , the response to lactate is mediated via Gpr1. This signalling is not dependent on the protein kinase C cell integrity pathway (Supplementary Fig. 8 ).
Lactate-dependent Crz1 targets include cell wall genes
We performed genome-wide transcriptional profiling to identify genes that might contribute to lactate-induced β-glucan masking in C. albicans and to investigate the impact of the Crz1 transcription factor. Using RNA sequencing, we compared glucose alone and glucose plus lactate cells, which grow at similar rates (Supplementary Table 1 ). The 157 lactate-regulated genes we identified were significantly enriched (P < 1 × 10 −5 ) in functions related to the plasma membrane, cell surface and cell periphery, consistent with the changes in cell wall β-glucan exposure (Supplementary  Table 2 ). Furthermore, the regulation of two-thirds of these 157 genes was compromised by CRZ1 inactivation, suggesting that they are either direct or indirect targets of Crz1 (Supplementary  Table 1 ). ACE2, encoding a transcription factor regulating cell wall integrity, protein mannosylation and chitin synthesis 29 , was induced in crz1Δ cells exposed to lactate. We also identified overlaps between Ace2 targets identified by ChIPSeq (ref. 30 ) and the genes highlighted by our RNA sequencing (Supplementary Table 3) . Therefore, the influence of ACE2 on lactate-induced β-glucan masking was tested. We examined ace2Δ cells by confocal and fluorescence microscopy because their aggregation, due to a severe cytokinesis defect 29 , precludes flow cytometry. The ace2Δ cells displayed high levels of β-glucan exposure in the presence of lactate (Fig. 4a,b) , indicating a block in masking. This suggests the involvement of a Crz1-Ace2 network in lactate-induced β-glucan masking (Fig. 5 and Supplementary Table 3) . We tested whether lactate-regulated cell wall genes influence lactate-induced β-glucan masking, reasoning that the outer mannan layer might contribute to masking 31, 32 (Fig. 4a,b ). Mnn14Δ cells did exhibit a partial masking defect (26.2% decrease in MFI; we define masking as a >50% decrease) (Fig. 4a) . However, mnn22Δ and exg2Δ cells retained the masking phenotype (Fig. 4a,b) , and although the levels of β-glucan exposure were elevated for cht2Δ and pga26Δ, lactate still triggered masking (Fig. 4a,b) . Also, our microscopic analyses of wild-type, gpr1Δ gpa2Δ and crz1Δ cells did not reveal a simple inverse relationship between mannan distribution and β-glucan exposure at the cell surface (Figs 2g,h  and 3c ). Therefore major changes in mannan distribution do not appear to account for lactate-induced β-glucan masking. We tested whether key cell wall crosslinking enzymes are required for this phenotype by examining a triple crh11Δ crh12Δ utr2Δ mutant that lacks three cell wall glycosidases. These cells displayed a gross increase in glucan exposure, but retained some degree of β-glucan masking ( Supplementary Fig. 9 ), suggesting that Crh11, Crh12 and Utr2 are not essential for masking.
Discussion
We have shown that L-lactate, generated by host cells or bacteria in the host's microbiota, actively triggers masking of a major PAMP at the fungal cell surface (Fig. 1) . This lactate-induced β-glucan masking phenotype, which is observed in a range of pathogenic Candida species (Fig. 1) , is triggered by physiologically relevant concentrations of lactate and is not activated by other host-derived metabolites such as acetate, methionine or proline (Fig. 2) . This PAMP masking correlates with reduced uptake of C. albicans cells by macrophages in vitro, decreased stimulation of TNFα and MIP1α by human macrophages and diminished recruitment of neutrophils in vivo (Fig. 1) .
Carbon source-mediated immune evasion is likely to be significant in the context of host colonization because C. albicans cells adapt rapidly to the mixtures of carbon sources offered by host niches (Fig. 2 and Supplementary Fig. 1 ) 17 . Lactate levels can reach 2-4 mM in blood and vaginal secretions and can comprise approximately 2% of all carbon metabolites generated by the gut microbiota 33 . Glucose is essentially absent from the colon, present at 3-5 mM in the blood, and at concentrations of up to 20 mM in vaginal secretions 11, 18, 34 . Although changes in additional PAMPs may contribute to the effects of carbon source, the importance of fungal β-glucan exposure and dectin-1-mediated fungal recognition is widely recognized [35] [36] [37] [38] . Taken together, the data indicate that changes in PAMP exposure occur as the fungus adapts to local nutrients within host niches, and this affects the visibility of the colonizing fungus to host immune defences. This idea is consistent with the observations that β-glucan exposure changes during the progression of systemic candidiasis 7, 9 , that C. albicans adaptation affects immune recognition by dectin-1 during systemic candidiasis 20 , and that changes in carbon source alter the virulence of C. albicans 12 .
How does lactate trigger β-glucan masking? We show that lactate triggers a signalling pathway that has co-opted the Gpr1 G-protein coupled receptor and the Crz1 transcription factor from the cAMP and calcineurin signalling pathways, respectively (Figs 2 and 3) . Maidan et al. showed that the Gpr1-Gpa2 module triggers filamentation in response to amino acid signals in a cAMP-independent fashion 23 . We hypothesize that a parallel pathway involving Gpr1, and possibly Gpa2, mediates lactate signalling to Crz1. This pathway does not require calcineurin, which is reminiscent of undefined calcineurin-independent modes of Crz1 regulation in other fungi 39, 40 . Crz1 then appears to regulate the expression of targets including ACE2 (Supplementary Table 1) , the inactivation of which affects lactate-induced β-glucan masking (Fig. 4) . Deletion of ACE2 also leads to β-glucan exposure at the S. cerevisiae cell surface 6 . In C. albicans, Crz1 regulates additional cell wall genes that may collectively mediate β-glucan masking (Figs 4 and 5 and  Supplementary Table 1) . However, individual cell wall mutations did not block this phenotype. Taken together, these observations support the view that PAMP masking is a polygenic trait that is influenced by cumulative changes in the quantity, crosslinking and organization of multiple cell wall macromolecules 6 and that the expression of these traits is modulated by lactate-Gpr1-Crz1 signalling (Fig. 5) .
How is β-glucan masked at the cell surface? β-Glucan is generally buried below the outer fibrillar layer of the C. albicans cell wall and is therefore masked by mannans. Mutations that compromise the mannan outer layer or glucan crosslinking cause β-glucan exposure at the cell surface (Fig. 4) . Mannan attachment to the inner glucanchitin layer is dependent on cell-wall-remodelling enzymes whose expression is affected by growth on different carbon sources 41 . Therefore, mannans play a general role in β-glucan masking and may contribute to lactate-induced masking. However, mutants with defects in individual cell wall genes are still capable of lactate-induced masking, suggesting that β-glucan masking is dependent on overall changes in the cell wall architecture.
In conclusion, this study reveals that C. albicans actively masks a major PAMP in response to host-derived carbon sources, essentially turning C. albicans into a moving target for the immune system in response to host-specific signals. This type of immune evasion is probably significant for disease progression in the host during periods of anaerobic metabolism (when lactic acid production is high), in the gastrointestinal tract (where anaerobic bacteria generate high lactate concentrations) and in patients with diabetes, shortbowel syndrome or bacterial infection (when serum lactate concentrations become elevated). This precedent, where C. albicans exploits host cues to modulate its immune visibility, may apply to other fungal pathogens (Fig. 1) 42, 43 .
Methods
Strains and culture conditions. The strains used in this study are listed in Supplementary Table 4 . In all cases, WT indicates the prototrophic parent of a given mutant strain, with the exception of SN152, for which auxotrophy has been demonstrated to have no impact on fungal virulence 44 . C. albicans was routinely cultured on YPD (1% yeast extract, 2% bacto-peptone, 2% glucose and 2% bactoagar) agar plates stored at room temperature. For glucose and lactate exposure, cells were incubated overnight at 30°C, 200 r.p.m. in 5 ml yeast nitrogen base (YNB) without amino acids (Sigma Y1250), prepared according to the manufacturer's instructions, plus 2% glucose and/or 2% D/L-lactate (Sigma, L1375) as indicated. All auxotrophic strains were grown in media with appropriate supplements.
BMDM phagocytosis assay. All experiments were conducted with the approval of the College of Life Sciences and Medicine Ethics Review Board, University of Aberdeen, and they all adhered to local and institutional policy requirements. C57BL/6 wild-type mice were bred and housed in the University of Aberdeen animal facility. Female mice aged 21 weeks were used to generate BMDMs by flushing femurs and tibia with RPMI 1640 GlutaMAX (Thermo Fisher Scientific) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (FCS; Sigma-Aldrich), 200 U ml −1 penicillin/streptomycin (Sigma) and 10 mM HEPES (Sigma). Bone marrow cells were cultured for 7 days at 37°C with 5% CO 2 in supplemented RPMI plus 15% (vol/vol) Lee's conditioned medium. Following cell counts, 1.2 × 10 5 BMDMs in 300 µl supplemented RPMI medium were seeded into eight-well imaging slides (ibidi) to adhere overnight. Phagocytosis assays were performed by combining 3:1 thimerosal-fixed yeast:adhered macrophages as described previously 45 . Immediately before imaging, wells were replenished with fresh CO 2 -independent medium (Thermo Fisher Scientific) supplemented with FCS and glutamine (Sigma). Conditions were maintained at 37°C with 5% CO 2 during 4 h image acquisition at 1 min intervals using an UltraVIEW VoX spinning disk microscope (Nikon) with Volocity software (Improvision, PerkinElmer). Triplicate movies were analysed for percent phagocytosis at 4 h post-inoculation for each condition with four independent experimental replicates (a total of 200-300 macrophages combined with approximately 600-800 yeast per condition). Data were analysed by Mann-Whitney U test using GraphPad Prism 7 (GraphPad Software). Variance within the groups was not statistically different (F test to compare variances, P = 0.1253).
Monocyte isolation, purification and macrophage differentiation. Blood from four healthy volunteers was collected according to local guidelines and regulations, approved by the College Ethics Review Board of the University of Aberdeen, and following obtaining informed consent of the donors (CERB/2012/11/676). PBMCs were isolated by Ficoll-Paque PLUS (GE Healthcare) density centrifugation according to the manufacturer's instructions. Highly pure unlabelled monocytes were obtained from PBMCs by depletion of non-monocytes using a magnetically activated cell sorting (MACS) system together with a human pan-monocyte isolation kit (Miltenyi Biotec). Purified monocytes were washed twice with PBS, and cells were suspended in RPMI 1640 (Dutch modification) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% MEM non-essential amino acids (NEAA (100×), Gibco), 100 U ml -1 penicillin, 100 mg ml -1 streptomycin and 50 ng ml
recombinant hGM-CSF (Gibco). Cells were seeded into cell culture dishes at a density of 1 × 10 6 cells per cm 2 and incubated at 37°C in a humidified atmosphere containing 5% CO 2 . On day 3, 10 ml fresh medium containing recombinant cytokines was added to the cultures. After 5 days, cells were collected, seeded into 24-well plates at a density of 1 × 10 5 cells per well and left overnight to adhere. Macrophages were fully activated with 50 ng ml -1 IFN-γ and 100 ng ml -1 LPS 24 h before co-culture with formaldehyde-fixed C. albicans yeast.
On the day of co-culture, macrophages were washed with PBS and fresh medium added. Then, C. albicans pre-grown in YNB glucose, glucose + lactate, or lactate for 4 h as described, fixed with 4% methanol-free formaldehyde (Thermo) and washed three times with sterile 1×PBS (Sigma), was added to each well at a multiplicity of infection (MOI) of 5:1 macrophages. For each donor, PBS-only wells were also included. At times 0, 6 and 24 h post-infection, 100 µl of supernatant was collected from each well and stored at −20°C. Cytokines and chemokines were quantified using the Luminex Screening kit (R&D) and read on a BioPlex 200 System (Bio-Rad) according to the manufacturer's recommendations. Statistical analyses were performed using Graph Pad Prism (v. 7), and significance was determined using the Friedman test for matched non-parametric data. Bars represent 95% confidence interval (CI).
Neutrophil recruitment assay. BALB/c female mice (n = 6 per group, 8-12 weeks old) were injected intraperitoneally with 1 × 10 7 C. albicans (SC5314) pre-grown in either glucose or lactate and then resuspended in 100 µl sterile saline. Group size was determined from previous experiments as the minimum number of mice needed to detect statistical significance (P < 0.05) with 90% power. Mice were randomly assigned to groups by an investigator not involved in the analysis, and the fungal inocula were randomly allocated to groups. Mice were house in individually ventilated cages (IVCs) and were provided with food and water ad libitum. Inocula were delivered in an unblinded fashion. After 4 h, mice were killed using the schedule 1 method, cervical dislocation. Immune infiltrates were collected by peritoneal lavage 46 . Cells were labelled to distinguish neutrophils (CD45 + , CD11b Quantification of β-glucan exposure in cell populations. Yeasts were grown in YNB + 2% glucose, +2% glucose and 2% lactate, or 2% lactate overnight, and inoculated into fresh medium for 4 h. Cells were stained for β-glucan exposure using Fc-Dectin-1 (ref. 47 ). Cells were counted by haemocytometer, and 2.5 × 10 6 cells were washed with cold FACS buffer (1 × PBS, 1% FCS, 0.5 mM EDTA). Cells were resuspended in 100 μl FACS buffer + 5 ng μl -1 dectin-Fc and incubated in the dark on ice for 1 h. Cells were washed (5,000 r.p.m., 3 min) twice in 100 µl FACS buffer and resuspended in 100 µl FACS buffer plus 1:200 Gt F(ab′)2 anti-human IgG (gamma) conjugated to Alexafluor 488 (Invitrogen, cat. no. H10120) or Novex TRITC (Abcam, cat. no. A18822), for GFP-expressing cells. Cells were incubated in the dark on ice for 1 h and washed as above. Cells were fixed in 4% formaldehyde (methanol-free), diluted in FACS buffer, and stored on ice in the dark until analysis using either a FACSCalibur flow cytometer or BD Fortessa flow cytometer. For each experiment, 10,000 events were acquired for each sample. Fresh glucose-grown C. albicans SC5314 cells were used as a positive control for each run. As a secondaryonly control, aliquots from all cells to be analysed were pooled, diluted to 2.5 × 10 6 cells and treated as above except that no dectin-Fc was added. MFI is reported for each sample as determined using FlowJo v. 10 software. This measure was selected as the most appropriate for the bimodal data observed for cells grown in glucose. Masking was defined as a more than 50% decrease in MFI based on six independent biological replicates of glucose versus glucose-lactate grown cells. Plots are representative of at least two biological replicates for strains with no masking defect and at least three biological replicates for strains with an observed masking defect.
Spent culture media. J774.1 macrophages (ECACC, HPA) were resuspended from liquid nitrogen stocks and grown to confluency in RPMI-1640 + L-glutamine + 10% FCS-HI + 100 U ml -1 penicillin + 100 μg ml -1 streptomycin. Cells were split and incubated for 3 days in fresh medium. The supernatant was collected and passed through a 0.45 μm filter. C. albicans SC5314 was pre-grown in YNB plus 2% glucose, washed with 1×PBS and incubated in fresh medium or spent, filtered supernatant for 6 h. Cells were stained for β-glucan as described above.
L. reuteri isolated from pig gut was a generous gift from K. Scott (Rowett Institute of Nutrition and Health, University of Aberdeen). L. reuteri was incubated overnight in M2 medium (Sigma) at 37°C, ambient air and at 200 r.p.m. Cells were spun down and the supernatant was collected and passed through a 0.45 μm filter. C. albicans SC5314 was pre-grown in YNB plus 2% glucose, washed with 1×PBS and incubated in fresh M2 or spent, filtered supernatant for 6 h. Cells were stained for β-glucan as described above and 10,000 cells were analysed by flow cytometry (n = 2).
Plasmid construction. GFP-tagged proteins were generated by cloning the relevant open reading frame (ORF) into CIp-NAT-GFP, which uses the CIp-NAT backbone 48 with the GFP ORF flanked by Age1 and Kas1 restriction sites to facilitate in-frame cloning under control of the ACT1 promoter. The GPR1 ORF was inserted at the Age1 restriction site to generate GPR1-GFP. The CRZ1 ORF was inserted in-frame at the Kas1 restriction site to generate GFP-CRZ1.
RNA extraction and analysis. Cells were incubated overnight in 5 ml volumes in the indicated conditions and transferred to fresh medium in 50 ml culture flasks for 4 h (30°C, 200 r.p.m.) to an optical density at 600 nm (OD 600 ) of 0.6. RNA was obtained via Qiazol/chloroform extraction (QIAgen) according to the manufacturer's instructions and assessed for quality by NanoDrop 1000 (Thermo Scientific). RNA was DNAse treated (TURBO DNAse, Ambion) according to the manufacturer's instructions and assessed for quality by an Agilent Bioanalyser (RNA integrity number > 8). Samples were processed through the Ion Torrent Proton sequencer (CGEBM University of Aberdeen Genomics facility). Raw fastq files were successively processed in the following order through Fastqc (v. 10.1), Trimgalore (v. 3.1), Samtools (v. 1.19), STAR aligner (v. 2.4) and Htseq (v. 5.4). Genome alignment was conducted against the C_albicans_SC5314_version_A21-s02-m09-r08 chromosomes file provided by the Candida Genome Database (http://www. candidagenome.org/) 49 . Aligned data were quality-controlled via the Partek Genomics Suite software, v. 6.6, according to the manufacturer's instructions. Biological replicates were grouped by genotype and growth medium, and exhibited similar variance within each condition. Gene expression analysis was performed using Partek Genomics Suite software using a log 2 data transformation as the Partek recommended default. Gene ontology (GO) term analysis was performed in parallel through the Candida Genome Database GO Term Finder and the Cytoscape v. 3 Clue GO plug-in 50 . Network construction was performed with Cytoscape V.3 freeware 51 . A statistical comparison among GO term enrichment percentages was performed with Graph Pad Prism (v. 6) using the Student's t-test for two-tailed data. Data represent three independent biological replicates for each condition.
Data availability. The RNA sequencing data set is available at EBI (http://www.ebi. ac.uk/arrayexpress/) under accession no. E-MTAB-4579. Other data that support the findings of this study are available from the corresponding author upon reasonable request.
